Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Lisa Veghini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3289-1189; OpenAlex author ID A5067619674. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
58
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 10

  1. Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation. Co-author DOI 10.1002/1878-0261.70233↗
  2. Estrogen Shapes Fibroblast States to Limit Pancreatic Cancer Aggressiveness. Co-author DOI 10.1158/0008-5472.can-25-4671↗
  3. Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Response and Associated with an Aggressive T… Co-author DOI 10.1158/2326-6066.cir-25-1602↗
  4. MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Co-author DOI 10.1038/s41586-025-08721-9↗
  5. SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-2330↗
  6. Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer. Co-author DOI 10.1038/s41467-024-54975-8↗
  7. Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC. Co-author DOI 10.1136/gutjnl-2023-329807↗
  8. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells. Co-author DOI 10.1016/j.modpat.2023.100251↗
  9. Loss of FGFR4 promotes the malignant phenotype of PDAC. Co-author DOI 10.1038/s41388-022-02432-5↗
  10. Cell Lineage Infidelity in PDAC Progression and Therapy Resistance. First author DOI 10.3389/fcell.2021.795251↗

Closest collaborators

The 25 strongest of 58 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vincenzo Corbo · 10 shared papers, 2021–2026 · strength 2.20
  2. Rita Teresa Lawlor · 5 shared papers, 2022–2025 · strength 0.71
  3. Aldo Scarpa Scarpa · 5 shared papers, 2022–2025 · strength 0.71
  4. Antonia Malinova · 4 shared papers, 2021–2025 · strength 0.62
  5. Francesca Lupo · 4 shared papers, 2022–2025 · strength 0.59
  6. Sabrina L. D’Agosto · 4 shared papers, 2022–2025 · strength 0.59
  7. Elena Fiorini · 4 shared papers, 2022–2025 · strength 0.59
  8. Claudio Luchini · 4 shared papers, 2022–2025 · strength 0.56
  9. Carmine Carbone · 3 shared papers, 2024–2025 · strength 0.48
  10. Peter J. Bailey · 3 shared papers, 2022–2025 · strength 0.43
  11. Pietro Delfino · 3 shared papers, 2022–2024 · strength 0.42
  12. Michèle Milella · 3 shared papers, 2022–2025 · strength 0.40
  13. Giulia Biffi · 2 shared papers, 2024–2025 · strength 0.36
  14. Antonio Agostini · 2 shared papers, 2024–2025 · strength 0.32
  15. David Arthur Tuveson · 2 shared papers, 2024–2025 · strength 0.32
  16. Geny Piro · 2 shared papers, 2024 · strength 0.31
  17. Giuseppe Malleo · 2 shared papers, 2023–2025 · strength 0.29
  18. Roberto Salvia · 2 shared papers, 2023–2025 · strength 0.29
  19. Paul A. Heppenstall · 1 shared paper, 2026 · strength 0.25
  20. Elena Cat Genova · 1 shared paper, 2026 · strength 0.25
  21. Antonio Pea · 2 shared papers, 2022–2023 · strength 0.23
  22. Giovanni Luigi Capretti · 1 shared paper, 2026 · strength 0.22
  23. Marika Viatore · 1 shared paper, 2026 · strength 0.22
  24. Marco Erreni · 1 shared paper, 2026 · strength 0.22
  25. Greta Donisi · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.